Factor Bioscience functional genomics, neurology news

Factor Bioscience, which is focusing on new technologies for the genetic and epigenetic engineering of cells, announced it received two Small Business Innovation Research (SBIR) grants to use its RiboSlice gene-editing technology to accelerate the development of new treatments for Alzheimer's disease. ...